Evaluation of the effects of COVID-19 on pregnancy, fetus and newborn, and treatment management.

Şenol Çomoğlu Sinan Öztürk Merve Caglar Ozer Barış Ertunç

Published in: Northern clinics of Istanbul (2022)

Pregnant women have more disadvantages in the course of COVID-19 and have worse maternal outcomes. In addition, treatments such as Lopinavir/Ritonavir and hydroxychloroquine did not have any effect. These patients should be carefully evaluated and followed up.

Keyphrases

coronavirus disease
pregnant women
sars cov
end stage renal disease
pregnancy outcomes
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
type diabetes
body mass index
birth weight
skeletal muscle
insulin resistance
replacement therapy
glycemic control
gestational age